Skip Navigation

Cardiovascular Research 2000 46(3):463-475; doi:10.1016/S0008-6363(00)00037-7
© 2000 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kupfahl, C.
Right arrow Articles by Regitz-Zagrosek, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kupfahl, C.
Right arrow Articles by Regitz-Zagrosek, V.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2000, European Society of Cardiology

Angiotensin II directly increases transforming growth factor β1 and osteopontin and indirectly affects collagen mRNA expression in the human heart

Claudio Kupfahla, Daniel Pinka, Katharina Friedricha, Heinz R. Zurbrüggb, Michael Neussa, Christina Warneckea, Jens Fielitza, Kristof Grafa, Eckart Flecka and Vera Regitz-Zagroseka,*

aInnere Medizin/Kardiologie, Virchow-Klinikum, Charité Humboldt University, and Deutsches Herzzentrum Berlin, Berlin, Germany
bHerz- Thorax- und Gefässchirurgie, Deutsches Herzzentrum Berlin, Berlin, Germany

* Corresponding author. Tel.: +49-30-4593-1000; fax: +49-30-4593-2500 zagrosek{at}dhzb.de

Objectives: Angiotensin II (Ang II) induces fibroblast proliferation and collagen synthesis in the myocardium, but its precise mechanisms of action in human hearts are still unknown. Therefore, we investigated whether Ang II directly affects the collagen mRNA content in the human myocardium and in isolated human cardiac fibroblasts or whether the growth factors TGFβ-1 and osteopontin are involved in this process. Methods and results I: In a first set of experiments, the direct effect of Ang II on collagen I, TGFβ-1 and osteopontin mRNA content in fresh samples of human atrial myocardium was determined by the use of a short stimulation period. After 4 h, Ang II-stimulated atrial samples gave a significantly higher expression of both TGFβ-1 (183±21% of control, p<0.05) and osteopontin mRNA (275±58%, p<0.02) than the controls. In contrast, the expression of collagen I mRNA was unchanged (95±8%). Stimulation with TGFβ-1 led to an increase in collagen I and III mRNA (127±10%, p<0.05; 140±15%, p<0.02). Methods and results II: In a second protocol, to assess the effects of longer stimulation periods, we determined the effects of Ang II and its potential mediator TGFβ-1 on collagen I, III and fibronectin mRNA expression and on proliferation of cultured human cardiac fibroblasts. Ang II caused a dose-dependent stimulation of proliferation but did not affect collagen I, III or fibronectin mRNA content after 24 h. In contrast, TGFβ-1 stimulation significantly increased collagen I and III mRNA expression (124±5% and 128±5%, p<0.002). Conclusions: In the human heart, Ang II does not directly increase collagen or fibronectin mRNA, but it does increase TGFβ-1 and osteopontin mRNA expression. Since TGFβ-1 induces collagen I and III mRNA in atrial samples and in isolated cardiac fibroblasts, it may represent a necessary mediator of the Ang II effects in the human heart.

KEYWORDS Ang II, Angiotensin II; AT1, AT2, angiotensin II receptor types 1 and 2; ADP, adenosine 5'-diphosphate; AMP, adenosine 5'-monophosphate; AP-1, activator protein 1; ATP, adenosine 5'-triphosphate; ATR, Ang II receptor; FN, fibronectin; HPLC, high-performance liquid chromatography; MAP, mitogen activated protein; mRNA, messenger RNA; OPN, osteopontin; PEA3, polyoma virus enhancer activator 3; PCR, polymerase chain reaction; PDH, pyruvic dehydrogenase; RT, reverse transcription; TGFβ-1, transforming growth factor β1


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
Y. K. On, E.-S. Jeon, S. Y. Lee, D.-H. Shin, J.-O. Choi, J. Sung, J. S. Kim, K. Sung, and P. Park
Plasma transforming growth factor beta1 as a biochemical marker to predict the persistence of atrial fibrillation after the surgical maze procedure.
J. Thorac. Cardiovasc. Surg., June 1, 2009; 137(6): 1515 - 1520.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. M. de Cavanagh, M. Ferder, F. Inserra, and L. Ferder
Angiotensin II, mitochondria, cytoskeletal, and extracellular matrix connections: an integrating viewpoint
Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H550 - H558.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
P. J Lijnen, V. V Petrov, and R. H Fagard
Angiotensin II-induced stimulation of collagen secretion and production in cardiac fibroblasts is mediated via angiotensin II subtype 1 receptors
Journal of Renin-Angiotensin-Aldosterone System, June 1, 2001; 2(2): 117 - 122.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.